• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
C.R. Bard, Inc. designs, develops, manufactures, distributes and markets medical technologies in the fields of vascular, urology, oncology and surgical specialty products. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Murray Hill, NJ.
Market Cap | 24.145 Billion | Shares Outstanding | 72.892 Million | Avg 30-day Volume | 928.437 Thousand |
P/E Ratio | 40.8464 | Dividend Yield | 0.3247 | EPS | 5.6 |
Price to Revenue | 6.0236 | Debt to Equity | 0.8144 | EBITDA | 954.8 Million |
Price to Book Value | 11.5683 | Operating Margin | 25.8889 | Enterprise Value | 23.687 Billion |
Current Ratio | 1.724 | EPS Growth | 0.121 | Quick Ratio | 1.107 |
1 Yr BETA | 0.7628 | 52-week High/Low | 0.0 / | Profit Margin | 14.7469 |
Operating Cash Flow Growth | 58.1779 | Free Cash Flow to Firm (FCFF) TTM | 687.809 Million | Free Cash Flow to Equity (FCFE) TTM | 764.309 Million |
Altman Z-Score | 5.2319 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
0 | 2017-12-29 | 0 | |
|
0 | 2017-12-29 | 0 | |
WEILAND JOHN H VICE CHAIRMAN, PRES. AND COO |
|
No longer subject to file | 2017-12-29 | 0 |
RING TIMOTHY M CHAIRMAN AND CEO |
|
No longer subject to file | 2017-12-29 | 0 |
|
0 | 2017-12-29 | 0 | |
HOLLAND CHRISTOPHER S SENIOR VICE PRESIDENT AND CFO |
|
No longer subject to file | 2017-12-29 | 0 |
|
0 | 2017-12-29 | 0 | |
|
0 | 2017-12-29 | 0 | |
LUPISELLA FRANK JR VICE PRESIDENT AND CONTROLLER |
|
No longer subject to file | 2017-12-29 | 0 |
|
0 | 2017-12-29 | 0 | |
DEFORD JOHN A SR. VP SCI TECH AND CLIN AFRS |
|
No longer subject to file | 2017-12-29 | 0 |
|
0 | 2017-12-29 | 0 | |
|
0 | 2017-12-29 | 0 | |
LUBOFF SHARON M GROUP VICE PRESIDENT |
|
No longer subject to file | 2017-12-29 | 0 |
COLLINS TIMOTHY P GROUP PRESIDENT |
|
No longer subject to file | 2017-12-29 | 0 |
BEASLEY JIM C GROUP PRESIDENT |
|
No longer subject to file | 2017-12-29 | 0 |
|
0 | 2017-12-29 | 0 | |
GROETELAARS JOHN P GROUP PRESIDENT |
|
No longer subject to file | 2017-12-29 | 0 |
KHICHI SAMRAT S. SR. VP, GEN COUNSEL & SECY. |
|
No longer subject to file | 2017-12-29 | 0 |
LARSON BETTY D VP - HUMAN RESOURCES |
|
No longer subject to file | 2017-12-29 | 0 |
PORRECA GERARD D III VP, QUALITY, REG & MED AFFAIRS |
|
No longer subject to file | 2017-12-29 | 0 |
CHRISTIAN PATRICIA G VP -QUALITY, REG & MED AFFAIRS |
|
12,422 | 2016-02-10 | 0 |
|
12,655 | 2015-12-09 | 0 | |
KELLY BRONWEN K VP - HUMAN RESOURCES |
|
22,420 | 2014-08-04 | 0 |
KREINDLER PETER M SR. VP, GEN COUNSEL & SECY. |
|
No longer subject to file | 2014-07-15 | 0 |
DOLCH GARY D SR. VP-QUALITY AND REG AFFAIRS |
|
27,466 | 2013-12-11 | 0 |
KELLY BRIAN P GROUP VICE PRESIDENT |
|
No longer subject to file | 2013-11-01 | 0 |
HOLLOWAY JEAN F VP, GEN COUNSEL AND SECRETARY |
|
11,397 | 2013-07-26 | 0 |
VALUEACT CAPITAL MASTER FUND, L.P. VALUEACT CAPITAL MANAGEMENT, L.P. |
|
2,861,380 | 2013-04-17 | 0 |
|
0 | 2013-01-02 | 0 | |
SCHERMERHORN TODD C SENIOR VICE PRESIDENT AND CFO |
|
86,618 | 2012-05-04 | 0 |
|
0 | 2012-01-20 | 0 | |
LONG STEPHEN J VP, GEN COUNSEL AND SECRETARY |
|
22,520 | 2011-11-08 | 0 |
|
0 | 2010-12-31 | 0 | |
NATALE JAMES L SR VP, PRES CORP HLTHCARE SVCS |
|
No longer subject to file | 2009-04-03 | 0 |
PAUL AMY S GROUP VICE PRESIDENT |
|
No longer subject to file | 2008-12-31 | 0 |
HOWARD JAMES M II VP-REGULATORY SCIENCES |
|
9,147 | 2008-07-09 | 0 |
GANSER CHRISTOPHER D VP-REGULATORY SCIENCES |
|
21,248 | 2006-07-12 | 0 |
REINSDORF JUDITH A VP, GENERAL COUNSEL, SECRETARY |
|
56,715 | 2006-07-12 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|
Holder | Issuer | Net Short Position | Position Date | Origin |
---|